Advancement in tumor treating fields of mechanism, clinical applications, and future directions
Authors:
Open Access
- 10 June 2025
- journal article
- review article
- Published by Springer Nature in Discover Oncology
- Vol. 16 (1) , 1-25
Abstract
Traditional cancer treatment modalities, such as surgical interventions, radiotherapy, and chemotherapy, persist as the cornerstone of standard care across a wide array of clinical settings. Despite their established effectiveness in combating cancer, these therapies are inherently invasive in nature and have great side effects, which seriously affect the quality of life of patients. Tumor Treating Fields is a low-intensity intermediate-frequency alternating electric field. Based on the current clinical study of Tumor Treating Fields in brain tumors, The U.S. Food and Drug Administration (FDA) initially approved Tumor Treating Fields in 2015 for the treatment of newly diagnosed or relapsed glioblastoma multiforme (GBM) and in 2019 for the treatment of malignant pleural mesothelioma (MPM). However, Tumor Treating Fields is still not widely appreciated in the treatment of high-mortality cancers, and although the therapeutic effect of Tumor Treating Fields has been validated in cell experiments and clinical trials, how to optimize its therapeutic effect remains to be studied. In this paper, the mechanism of Tumor Treating Fields treatment and its clinical progress were reviewed, and the dosimetry and numerical simulation of individualized treatment were comprehensively summarized, in order provide new ideas for further clinical research of this treatment model.Keywords
This publication has 113 references indexed in Scilit:
- Annual report to the nation on the status of cancer, part 1: National cancer statisticsCancer, 2022
- Skull defect increases the tumor treating fields strength without detrimental thermogenic effect: A computational simulating researchCancer Medicine, 2022
- Understanding the Blood‐Brain Barrier and Beyond: Challenges and Opportunities for Novel CNS TherapeuticsClinical Pharmacology & Therapeutics, 2022
- Tumor-Treating Fields at EMBC 2019: A Roadmap to Developing a Framework for TTFields Dosimetry and Treatment Planning2020
- Estimation of TTFields Intensity and Anisotropy with Singular Value Decomposition: A New and Comprehensive Method for Dosimetry of TTFields2019
- Investigating the Connection Between Tumor-Treating Fields Distribution in the Brain and Glioblastoma Patient Outcomes. A Simulation-Based Study Utilizing a Novel Model Creation Technique2019
- Influence of Treatment With Tumor-Treating Fields on Health-Related Quality of Life of Patients With Newly Diagnosed GlioblastomaJAMA Oncology, 2018
- Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With GlioblastomaJAMA, 2017
- Alternating electric fields (TTFields) in combination with paclitaxel are therapeutically effective against ovarian cancer cells in vitro and in vivoInternational Journal of Cancer, 2016
- Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for GlioblastomaJAMA, 2015